Dechra Pharmaceuticals Claimed Company
Dechra is an international specialist veterinary pharmaceuticals and related products business. read more
HR or Marketing? Claim Your Free Employer Account
Dechra Pharmaceuticals VP of Investor Relations Salary
The average Dechra Pharmaceuticals VP of Investor Relations earns an estimated $127,300 annually. Dechra Pharmaceuticals' VP of Investor Relations compensation is $4,108 less than the US average for a VP of Investor Relations.
Last updated 2 years ago.
$77k
$120k
$129k
$225k
$127,300
Average Compensation
- $127,300
- avg. base
VP of Investor Relations Salaries at Dechra Pharmaceuticals
Compensation at Dechra Pharmaceuticals by Department
How VPs of Investor Relations at Dechra Pharmaceuticals Rate Their Compensation
The majority of VPs of Investor Relations at Dechra Pharmaceuticals believe they're compensated fairly. The vast majority (75%) of VPs of Investor Relations at Dechra Pharmaceuticals are satisfied with their benefits. See more compensation ratings at Dechra Pharmaceuticals
VP of Investor Relations Salaries at Similar Size Companies
×